Nanotechnology Now - Press Release: Forbes, Advanced Materials & EETimes Coverage of Shrink Nanotechnologies Caps off Successful 2009

Home > Press > Forbes, Advanced Materials & EETimes Coverage of Shrink Nanotechnologies Caps off Successful 2009

Abstract:
Scientific Breakthrough Technology for Solar Energy Technology, Medical Diagnostics & Stem Cell Research Tools Products Receives National Recognition & High Praise from Top-Tier Business Press, Trade Publications & Regional Dailies

Company Relaunches ShrinkNano.com Web Site

Commences New Monthly Newsletter in January 2010

Forbes, Advanced Materials & EETimes Coverage of Shrink Nanotechnologies Caps off Successful 2009

Carlsbad, CA | Posted on December 15th, 2009

Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB: INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, today highlighted the rapid achievements accomplished in 2009. The ground-breaking innovations developed by the company's scientific founder have received national recognition in top-tier business press, leading trade publications and regional dailies. Shrink also announced today a relaunch of its Web site - www.ShrinkNano.com - along with the ability to download shareholder information and the most up-to-date press kit. A new monthly newsletter geared towards investors that want to be kept informed on company developments, the latest advances in solar energy technology and healthcare testing will commence in January 2010.

"This has been a watershed year for Shrink, where we successfully built the foundation of the company by bringing together the leading minds of finance, industry, government and academia to truly revolutionize the solar, biotechnology and diagnostics industries. We'll look back at 2009 as our coming out party and how we effectively introduced ourselves to the various markets, leading media and potential investors," said Mark L. Baum, CEO of Shrink Nanotechnologies. "The last year has paved the way for a breakout 2010 - where the company expects to bring its first products to market. We're extremely excited that we're going to be offering [game-changing] innovations to each of these industries, but more importantly, improving people's lives."

Since Dr. Michelle Khine, the scientific founder of Shrink's nanofabrication platform, was named by the MIT Technology Review Magazine as one of the top 35 global innovators under the age of 35, Shrink has been in the media spotlight, garnering several features in top-tier business, industry trade publications and regional newspapers.

Most notably, Dr. Khine was profiled in Forbes.com as part of the online series called the "Revolutionaries," describing her as the 'MacGyver' of bioengineering by creating a quick and affordable way to manufacture medical diagnostic chips. As she develops the technology, one area she hopes the chips will flourish in is the detection of infectious diseases in developing countries, where equipment, resources and trained personnel are often lacking. The company and its technology were also featured in Equities Magazine, EETimes and numerous other outlets including Carlsbad's regional newspapers North County Times and Ventura County Star. Other notable mentions of Shrink, including some cover stories, can be found in Advanced Materials, Renewable Energy Focus, Medical Device Link, ZDNet, PhysOrg.com and Switched.com.

Shrink also announced the relaunch of www.ShrinkNano.com, which enables users to easily navigate the site and access information about Shrink, including management bios, details on its scientific advisors, strategic business focus, products details, company news and media coverage. In addition, the site includes extensive information about the company's three target industries, Solar, Biological Research and Diagnostics, including market size and forecasted growth, and details on Shrink's plan of approach to roll out products in each market.

Those products include:

* OptiSol™ Solar Concentrator: Optisol Solar window is designed to increase power output and make solar economically competitive. This product is an accessory for existing silicon solar systems.

* Biotech Research tools: StemDisc™, CellAlign™, and Rapid Prototyping System™ are all geared toward enabling stem cell and drug discovery researchers quest to cure some of the world's deadliest diseases.

* Diagnostics: MetalFluor™ has been designed to assist diagnostic companies to make health care tests more sensitive and reliable at a lower cost.

Lastly, Shrink has launched the inaugural edition of its monthly newsletter for investors. The newsletter will include a message from the CEO, company-related and provocative industry news, updates and data for each developing product, videos and press. If interested in receiving Shrink's monthly newsletter, please sign up at www.shrinknano.com/more-info-newsletter/.

Learn more about Shrink Nanotechnologies, Inc. and download the most up-to-date shareholder kit at www.shrinknano.com as well as www.shrinksolar.com.

####

About Shrink Nanotechnologies
Shrink is a first of its kind FIGA™ organization. FIGA companies are “for profit” businesses that bring together diverse contributions from leaders in the worlds of finance, industry, government and academia. Shrink’s solutions, including its diverse polymer substrates, nano-devices and biotech research tools, among others, are designed to be ultra-functional and mechanically superior in the solar energy, environmental detection, stem cell and biotechnology markets. The Company’s products are based on proprietary material, a pre-stressed plastic called NanoShrink™, and on their patent-pending manufacturing process called the ShrinkChip Manufacturing Solution™. Shrink’s unique materials and manufacturing solution represents a new paradigm in the rapid design, low-cost fabrication and manufacture of nano-scale devices for the markets they serve.

For more information, please click here

Contacts:
Brainerd Communicators
Scott Cianciulli
212-986-6667

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: